12 Health Care Stocks Moving In Friday's Intraday Session
Portfolio Pulse from Benzinga Insights
Health care stocks experienced significant movements in Friday's intraday session, with Maravai LifeSciences leading the gainers after reporting Q4 earnings, and ModivCare heading the losers also following its Q4 earnings release. Other notable movers include Ocean Biomedical, Monopar Therapeutics, and Gyre Therapeutics on the gainers' side, and Venus Concept, SeaStar Medical Holding, and ImmunityBio among the losers.
February 23, 2024 | 5:31 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
ModivCare's stock fell 36.2% to $27.97 following its Q4 earnings, with a market cap of $396.8 million.
The decline in MODV's stock price is a direct consequence of its Q4 earnings release, likely due to disappointing results or negative future guidance.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100
POSITIVE IMPACT
Maravai LifeSciences stock surged 65.5% to $8.46 after Q4 earnings, with a market cap of $1.1 billion.
The significant surge in MRVI's stock price is directly attributed to its Q4 earnings release, indicating strong performance or positive future outlook.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100
POSITIVE IMPACT
Ocean Biomedical shares rose 58.59% to $0.87, with a market cap of $29.7 million.
The sharp increase in OCEA's stock price could be attributed to positive market sentiment or speculative trading, as no specific catalyst is mentioned.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 80